Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (271-280 of 368) with videos related to

Pageof 37
Sort By:
The Lancet. Global Health|February 18, 2022
Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trialElizabeth C George, Sophie Uyoga, Bridon M'baya, et al.
Journal of Clinical Microbiology|June 5, 2020
Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE TrialWilly Ssengooba, Jean de Dieu Iragena, Lydia Nakiyingi, et al.
BMC Pediatrics|January 5, 2024
Effects of the COVID-19 pandemic on the outcomes of HIV-exposed neonates: a Zimbabwean tertiary hospital experienceHannah Gannon, Elizabeth Chappell, Deborah Ford, et al.
AIDS (London, England)|April 26, 2007
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in childrenH Green, D M Gibb, A S Walker, et al.
Plos Medicine|November 15, 2017
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trialAlexander J Szubert, Andrew J Prendergast, Moira J Spyer, et al.
Open Forum Infectious Diseases|July 18, 2024
Subcortical Brain Volumes and Neurocognitive Function in Children With Perinatal HIV Exposure: A Population-Based Cohort Study in South AfricaCatherine J Wedderburn, Shunmay Yeung, Nynke A Groenewold, et al.
The Lancet. Infectious Diseases|February 4, 2011
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Abdel Babiker, Hannah Castro nee Green, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Age-dependent pharmacokinetics of lamivudine in HIV-infected childrenD M Burger, G Verweel, N Rakhmanina, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2016
Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project ExperienceDeborah Ford, Margaret Muzambi, Misheck J Nkhata, et al.
BMJ (Clinical Research Ed.)|April 17, 2014
The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trialsEthan K Gough, Erica E M Moodie, Andrew J Prendergast, et al.
Pageof 37

Showing results (271-280 of 368) with videos related to

Sort By:
Pageof 37
The Lancet. Global Health|February 18, 2022
Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trialElizabeth C George, Sophie Uyoga, Bridon M'baya, et al.
Journal of Clinical Microbiology|June 5, 2020
Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE TrialWilly Ssengooba, Jean de Dieu Iragena, Lydia Nakiyingi, et al.
BMC Pediatrics|January 5, 2024
Effects of the COVID-19 pandemic on the outcomes of HIV-exposed neonates: a Zimbabwean tertiary hospital experienceHannah Gannon, Elizabeth Chappell, Deborah Ford, et al.
AIDS (London, England)|April 26, 2007
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in childrenH Green, D M Gibb, A S Walker, et al.
Plos Medicine|November 15, 2017
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trialAlexander J Szubert, Andrew J Prendergast, Moira J Spyer, et al.
Open Forum Infectious Diseases|July 18, 2024
Subcortical Brain Volumes and Neurocognitive Function in Children With Perinatal HIV Exposure: A Population-Based Cohort Study in South AfricaCatherine J Wedderburn, Shunmay Yeung, Nynke A Groenewold, et al.
The Lancet. Infectious Diseases|February 4, 2011
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Abdel Babiker, Hannah Castro nee Green, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Age-dependent pharmacokinetics of lamivudine in HIV-infected childrenD M Burger, G Verweel, N Rakhmanina, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2016
Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project ExperienceDeborah Ford, Margaret Muzambi, Misheck J Nkhata, et al.
BMJ (Clinical Research Ed.)|April 17, 2014
The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trialsEthan K Gough, Erica E M Moodie, Andrew J Prendergast, et al.
Pageof 37